package-statement:
  id: PS-AFT
  title: Borstreconstructie middels autologe vettransplantatie (AFT) na uitwendige weefsel expansie met een externe expander bij vrouwen met een totale borstverwijdering na borstkanker of ter preventie wegens genetische predispositie
  date: 2023-01-01
  package-type: PointOfView
  case-number: 2022006448
  serial-number: 2022006461
  status: Definitive
  contact-person: [Ingrid de Groot,Angèl Link,Steef Redeker,Yoka Kusumanto]
  department: Zorg 1
  team: Pakket en Advies
  see-also: "https://www.zorginstituutnederland.nl/documenten/2023/01/01/standpunt-aft-na-een-totale-borstverwijdering"
  guarantee-document: "https://www.zorginstituutnederland.nl/site/binaries/site-content/collections/documents/2023/01/01/standpunt-aft-na-een-totale-borstverwijdering/Waarborgendocument+autologe+vettransplantatie.pdf"
  iic-assessments:
  - IICAssessment-AFT

populations:
  - id: Population-WomenSimpleMastectomyAfterBreastCancer
    title: Vrouwen die besloten hebben tot borstreconstructie na totale borstverwijdering ter behandeling van borstkanker
    sex: Female
    age: 
    conditions:
      - Breast Cancer
    treatment: [Simple mastectomy]
  - id: Population-WomenSimpleMastectomyWithGeneticPredisposition
    title: Vrouwen die besloten hebben tot borstreconstructie na totale borstverwijdering ter preventie van borstkanker wegens genetische predispositie
    age: 
    conditions:
      - Genetic predisposition to breast cancer
    treatment: [Simple mastectomy]

interventions:
  # TODO: Add Dutch title
  - id: Intervention-AFT
    title: Autologe vettransplantatie (AFT)
    applied-intervention: Autologous fat transplantation (AFT)
    intervention-rationale: Verbeteren esthetisch resultaat
    intervention-classification: Surgical
  - id: Intervention-BRAVA
    title: Uitwendige weefsel expansie met BRAVA
    applied-intervention: Breast Tissue Expander
    intervention-rationale: Weefsel expansie voor AFT
    intervention-classification: Medical Devices
  - id: Intervention-AFT-BRAVA
    title: Autologe vettransplantatie (AFT) na uitwendige weefsel expansie met BRAVA
    applied-intervention: Autologous fat transplantation (AFT) after external tissue expansion using BRAVA
    intervention-rationale: Herstellen borstvolume en -vorm
    intervention-classification: Surgical
    marketing-authorization-holder: 
    claim-code: 
    care-activity-code: "033973"
    care-product-code: "982017017"
    costs: 5_565 
    child-interventions:
    - Intervention-AFT
    - Intervention-BRAVA
  - id: Intervention-IBR
    title: Implant-based breast reconstruction (IBR)
    applied-intervention: Implant-based breast reconstruction (IBR)
    intervention-rationale: Herstellen borstvolume en -vorm
    intervention-classification: Surgical
    marketing-authorization-holder: 
    claim-code:
    care-activity-code:
    care-product-code: "990004080"
    costs: 3_975
  - id: Intervention-ABR
    title: Autologe borstreconstructie (ABR)
    applied-intervention: Autologous breast reconstruction (ABR)
    intervention-rationale: Herstellen borstvolume en -vorm
    intervention-classification: Surgical
    marketing-authorization-holder: 
    claim-code:
    care-activity-code: 
    care-product-code: "990004018"
    costs: 14_490

intervention-groups:
  - id: InterventionGroup-AFT
    title: Borstreconstructie met AFT
    intervention-ids: [Intervention-AFT-BRAVA]
  - id: InterventionGroup-IBRorABR
    title: Borstreconstructie met IBR of ABR
    intervention-ids: [Intervention-IBR, Intervention-ABR]

outcomes:
  # MammaOnco
  - id: Outcome-BreastvolumeRetention
    name: Breast volume retention
    outcome-classification: Aesthetic
    outcome-measurement: Breast volume retention
    specific-metric: 3D fotografie met VECTRA®XT (ml)
    surrogate-outcome: False
  - id: Outcome-BREASTQPatientSatisfactionWithBreast
    name: Patient satisfaction with breast
    outcome-classification: Patient-reported
    outcome-measurement: BREAST-Q - satisfaction with breast
    surrogate-outcome: False
  - id: Outcome-SeriousPerioperativeComplications
    name: Serious perioperative complications
    outcome-classification: Adverse events
    outcome-measurement: Number of serious complications
    surrogate-outcome: False
  - id: Outcome-LocoregionalOncologicEvents
    name: Locoregional oncologic events
    outcome-classification: Adverse events
    outcome-measurement: Number of locoregional oncologic events
    surrogate-outcome: False
  - id: Outcome-BREASTQPhysicalWellbeing
    name: BREAST-Q - physical wellbeing
    outcome-classification: Patient-reported
    outcome-measurement: BREAST-Q - physical wellbeing
    surrogate-outcome: False
  - id: Outcome-BREASTQPsychosocialWellbeing
    name: BREAST-Q - psychosocial wellbeing
    outcome-classification: Patient-reported
    outcome-measurement: BREAST-Q - psychosocial wellbeing
    surrogate-outcome: False
  - id: Outcome-BREASTQSexualWellbeing
    name: BREAST-Q - sexual well-being
    outcome-classification: Patient-reported
    outcome-measurement: BREAST-Q - sexual well-being
    surrogate-outcome: False
  - id: Outcome-NonSeriousSideEffects
    name: Non-serious side effects
    outcome-classification: Adverse events
    outcome-measurement: Number of non-serious side effects
    surrogate-outcome: False

outcome-groups:
  - id: OutcomeGroup-AFT-Between6to12MonthsPostIntervention
    endpoint: Between 6 and 12 months post-intervention
    outcome-ids: [Outcome-BreastvolumeRetention, Outcome-LocoregionalOncologicEvents]
  - id: OutcomeGroup-AFT-Between12MonthsPostIntervention
    endpoint: "12 months post-intervention"
    outcome-ids: [Outcome-BREASTQPatientSatisfactionWithBreast, Outcome-BREASTQPhysicalWellbeing, Outcome-BREASTQPsychosocialWellbeing, Outcome-BREASTQSexualWellbeing]
  - id: OutcomeGroup-AFT-PeriAndPostOperativeTill12MonthsPostIntervention
    endpoint: "12 Peri- en postoperative till 12 months postintervention"
    outcome-ids: [Outcome-SeriousPerioperativeComplications, Outcome-NonSeriousSideEffects]
  - id: OutcomeGroup-AFT-12to60MonthsPostIntervention
    outcome-ids: [Outcome-LocoregionalOncologicEvents]
    endpoint: "12 to 60 months post-intervention"

picots:
  - id: PICOT-AFT
    population-ids:
    - Population-WomenSimpleMastectomyAfterBreastCancer
    - Population-WomenSimpleMastectomyWithGeneticPredisposition
    intervention-group-id: InterventionGroup-AFT
    comparator-group-id: InterventionGroup-IBRorABR
    outcome-group-ids:
    - OutcomeGroup-AFT-Between6to12MonthsPostIntervention
    - OutcomeGroup-AFT-Between12MonthsPostIntervention
    - OutcomeGroup-AFT-PeriAndPostOperativeTill12MonthsPostIntervention
    - OutcomeGroup-AFT-12to60MonthsPostIntervention

intervention-indication-combination-assessments:
  - id: IICAssessment-AFT
    assessment-type: Initial
    intervention-id: Intervention-AFT-BRAVA
    indication-ids:
    - Population-WomenSimpleMastectomyAfterBreastCancer
    - Population-WomenSimpleMastectomyWithGeneticPredisposition
    emsmp-id: EMSMP-AFT
    bia-id: BIA-AFT
    au-id: AU-AFT
    conclusion: Positive
    conclusion-text: "Sacituzumab govitecan voldoet aan de stand van de wetenschap en praktijk bij de behandeling van volwassen patiënten met inoperabele of gemetastaseerde triplenegatieve borstkanker, die twee of meer eerdere systemische therapieën hebben gekregen, waaronder één lijn taxaanbevattende therapie en tenminste één voor gevorderde ziekte. Het Zorginstituut adviseert u sacituzumab govitecan op te nemen in het verzekerde pakket voor deze indicatie. Het Zorginstituut acht een korting van tenminste 55% aangewezen. Zoals het Zorginstituut u in 2022 reeds adviseerde, dient bij de onderhandelingen te worden meegenomen dat indicatie-uitbreidingen van sacituzumab govitecan te verwachten zijn."
    cost-effective: False

emsmps: # Established Medical Science and Medical Practice
  - id: EMSMP-AFT
    title: Established Medical Science and Medical Practice - AFT
    picots-id: PICOT-AFT
    slr-id: SLR-AFT
    outcome-measurement-ids:
    - OutcomeMeasurement-BreastvolumeRetention-SMD
    - OutcomeMeasurement-SeriousPerioperativeComplications-RR
    - OutcomeMeasurement-SeriousPerioperativeComplications-AbsoluteDifference
    - OutcomeMeasurement-LocoregionalOncologicEvents-RR
    - OutcomeMeasurement-LocoregionalOncologicEvents-AbsoluteDifference
    - OutcomeMeasurement-BREASTQPatientSatisfactionWithBreast-MD
    - OutcomeMeasurement-BREASTQPhysicalWellbeing-MD
    - OutcomeMeasurement-BREASTQPsychosocialWellbeing-MD
    - OutcomeMeasurement-BREASTQSexualWellbeing-MD
    # relative-effectiveness: Equal
    adheres-to-emsmps: True


systematic-literature-reviews:
  - id: SLR-AFT
    title: Systematisch literatuuronderzoek voor AFT
    literature-searches: 
    - LS-AFT-Embase-RCT-2022-04-28
    - LS-AFT-Medline-RCT-2022-04-28
    - LS-AFT-Cochrane-RCT-2022-04-28
    - LS-AFT-Embase-SystematicReview-2022-04-28
    - LS-AFT-Medline-SystematicReview-2022-04-28
    - LS-AFT-Cochrane-SystematicReview-2022-04-28
    literature-reference-list: LRL-AFT

literature-searches:
  - id: LS-AFT-Embase-RCT-2022-04-28
    label: Literatuur zoekopdracht voor RCTs voor AFT in Embase op 2022-04-28
    end-time: 2022-04-28T00:00:00
    target-db: Embase
    target-url: https://www.embase.com/
    evidence-type: RCT
    query: >-
      ('autologous fat'/de OR 'lipotransfer'/de OR 'lipomodelling'/de OR 'adipose tissue transplantation'/de OR (('adipose tissue'/exp) AND ('transplantation'/de )) OR 'autologous fat grafting'/de OR 'autologous fat transplantation'/de OR 'autologous fat transfer'/de OR 'autologous fat graft'/de OR 'autologous fat injection'/de OR (((autolog*) NEAR/3 (fat*)) OR lipostruct* OR lipotransfer* OR lipomodel* OR lipofill* OR ((fat*) NEAR/3 (transplant* OR graft* OR transfer* OR inject* OR infiltrate*)) OR reverse-expan*):ab,ti,kw) AND ('breast tumor'/exp OR 'mastectomy'/exp OR (mammaplast* OR mammoplast* OR mastoplast* OR mastectom* OR ((breast* OR mamma*) NEAR/3 (tumor* OR tumour* OR neoplas* OR carcino* OR cancer* OR malignan*)) OR ((breast* OR mamma*) NEAR/6 (oncol*)) OR mammacarcin*):ab,ti,kw) AND ('clinical study'/exp OR (((clinical* OR case* OR family* OR intervent* OR longitudinal* OR open OR prospect* OR retrospect* OR multicent*) NEAR/2 (study OR studies OR article* OR trial* OR evaluation*)) OR case-report* OR case-serie* OR ((communit*) NEAR/2 (trial*)) OR RCT OR RCTS OR randomi* OR placebo* OR ((single* or double* or triple* or treble*) AND (blind* or mask*)) OR ((phase*) NEAR/3 (1 OR one OR I OR 2 OR two OR II OR 3 OR three OR III OR 4 OR four OR IV) NEAR/6 (trial* OR stud*))):ab,ti,kw) NOT ([Conference Abstract]/lim OR 'editorial'/it OR 'letter'/it OR 'note'/it OR 'chapter'/it OR 'conference abstract'/it OR 'conference paper'/it OR 'conference review'/it OR 'editorial'/it OR 'erratum'/it OR [preprint]/lim) NOT ('systematic review'/de OR 'systematic review (topic)'/de OR (systematic-review*):ab,ti,kw)
  - id: LS-AFT-Medline-RCT-2022-04-28
    label: Literatuur zoekopdracht voor RCTs voor AFT in Medline op 2022-04-28
    end-time: 2022-04-28T00:00:00
    target-db: Medline
    target-url: https://www.medline.com/
    evidence-type: RCT
    query: >-
      (((exp "Adipose Tissue"/) AND ("Transplantation"/ OR "Transplantation, Autologous"/ OR "Tissue Transplantation"/ OR tr.fs)) OR (((autolog*) ADJ3 (fat*)) OR lipostruct* OR lipotransfer* OR lipomodel* OR lipofill* OR ((fat*) ADJ3 (transplant* OR graft* OR transfer* OR inject* OR infiltrate*)) OR reverse-expan*).ab,ti,kf.) AND (exp "Breast Neoplasms"/ OR exp "Mastectomy"/ OR (mammaplast* OR mammoplast* OR mastoplast* OR mastectom* OR ((breast* OR mamma*) ADJ3 (tumor* OR tumour* OR neoplas* OR carcino* OR cancer* OR malignan*)) OR ((breast* OR mamma*) ADJ6 (oncol*)) OR mammacarcin*).ab,ti,kf.) AND ("Clinical Study".pt OR "Clinical Trial".pt OR "Adaptive Clinical Trial".pt OR "Clinical Trial, Phase I".pt OR "Clinical Trial, Phase II".pt OR "Clinical Trial, Phase III".pt OR "Clinical Trial, Phase IV".pt OR "Controlled Clinical Trial".pt OR "Randomized Controlled Trial".pt OR "Equivalence Trial".pt OR "Pragmatic Clinical Trial".pt OR "Clinical Trial Protocol".pt OR "Observational Study".pt OR exp "Clinical Studies as Topic"/ OR (((clinical* OR case* OR family* OR intervent* OR longitudinal* OR open OR prospect* OR retrospect* OR multicent*) ADJ2 (study OR studies OR article* OR trial* OR evaluation*)) OR case-report* OR case-serie* OR ((communit*) ADJ2 (trial*)) OR RCT OR RCTS OR randomi* OR placebo* OR ((single* or double* or triple* or treble*) AND (blind* or mask*)) OR ((phase*) ADJ3 (1 OR one OR I OR 2 OR two OR II OR 3 OR three OR III OR 4 OR four OR IV) ADJ6 (trial* OR stud*))).ab,ti,kf.) NOT ("Editorial".pt. OR "Comment".pt. OR "Letter".pt. OR "News".pt. OR "Congress".pt. OR "Meeting Abstract".pt. OR "Abstracts".pt. OR "Academic Dissertation".pt. OR "Published Erratum".pt. OR (book* OR chapter* OR dissertation abstract*).pt.) NOT ("Systematic Reviews as Topic"/ OR "Systematic Review".pt. OR (systematic-review*).ab,ti,kf.)
  - id: LS-AFT-Cochrane-RCT-2022-04-28
    label: Literatuur zoekopdracht voor RCTs voor AFT in Cochrane op 2022-04-28
    end-time: 2022-04-28T00:00:00
    target-db: Cochrane
    target-url: https://www.cochranelibrary.com/
    evidence-type: RCT
    query: >-
      ((((autolog*) NEAR/3 (fat*)) OR lipostruct* OR lipotransfer* OR lipomodel* OR lipofill* OR ((fat*) NEAR/3 (transplant* OR graft* OR transfer* OR inject* OR infiltrate*)) OR reverseexpan*):ab,ti,kw) AND ((mammaplast* OR mammoplast* OR mastoplast* OR mastectom* OR ((breast* OR mamma*) NEAR/3 (tumor* OR tumour* OR neoplas* OR carcino* OR cancer* OR malignan*)) OR ((breast* OR mamma*) NEAR/6 (oncol*)) OR mammacarcin*):ab,ti,kw) AND ((((clinical* OR case* OR family* OR intervent* OR longitudinal* OR open OR prospect* OR retrospect* OR multicent*) NEAR/2 (study OR studies OR article* OR trial* OR evaluation*)) OR case-report* OR case-serie* OR ((communit*) NEAR/2 (trial*)) OR RCT OR RCTS OR randomi* OR placebo* OR ((single* or double* or triple* or treble*) AND (blind* or mask*)) OR ((phase*) NEAR/3 (1 OR one OR I OR 2 OR two OR II OR 3 OR three OR III OR 4 OR four OR IV) NEAR/6 (trial* OR stud*))):ab,ti,kw).
  - id: LS-AFT-Embase-SystematicReview-2022-04-28
    label: Literatuur zoekopdracht voor Systematic Reviews on AFT in Embase op 2022-04-28
    end-time: 2022-04-28T00:00:00
    target-db: Embase
    target-url: https://www.embase.com/
    evidence-type: Systematic Review
    query: >-
      ('autologous fat'/de OR 'lipotransfer'/de OR 'lipomodelling'/de OR 'adipose tissue transplantation'/de OR (('adipose tissue'/exp) AND ('transplantation'/de )) OR 'autologous fat grafting'/de OR 'autologous fat transplantation'/de OR 'autologous fat transfer'/de OR 'autologous fat graft'/de OR 'autologous fat injection'/de OR (((autolog*) NEAR/3 (fat*)) OR lipostruct* OR lipotransfer* OR lipomodel* OR lipofill* OR ((fat*) NEAR/3 (transplant* OR graft* OR transfer* OR inject* OR infiltrate*)) OR reverse-expan*):ab,ti,kw) AND ('breast tumor'/exp OR 'mastectomy'/exp OR (mammaplast* OR mammoplast* OR mastoplast* OR mastectom* OR ((breast* OR mamma*) NEAR/3 (tumor* OR tumour* OR neoplas* OR carcino* OR cancer* OR malignan*)) OR ((breast* OR mamma*) NEAR/6 (oncol*)) OR mammacarcin*):ab,ti,kw) AND ('systematic review'/de OR 'systematic review (topic)'/de OR (systematic-review*):ab,ti,kw)
  - id: LS-AFT-Medline-SystematicReview-2022-04-28
    label: Literatuur zoekopdracht voor Systematic Reviews on AFT in Medline op 2022-04-28
    end-time: 2022-04-28T00:00:00
    target-db: Medline
    target-url: https://www.medline.com/
    evidence-type: Systematic Review
    query: >-
      (((exp "Adipose Tissue"/) AND ("Transplantation"/ OR "Transplantation, Autologous"/ OR "Tissue Transplantation"/ OR tr.fs)) OR (((autolog*) ADJ3 (fat*)) OR lipostruct* OR lipotransfer* OR lipomodel* OR lipofill* OR ((fat*) ADJ3 (transplant* OR graft* OR transfer* OR inject* OR infiltrate*)) OR reverse-expan*).ab,ti,kf.) AND (exp "Breast Neoplasms"/ OR exp "Mastectomy"/ OR (mammaplast* OR mammoplast* OR mastoplast* OR mastectom* OR ((breast* OR mamma*) ADJ3 (tumor* OR tumour* OR neoplas* OR carcino* OR cancer* OR malignan*)) OR ((breast* OR mamma*) ADJ6 (oncol*)) OR mammacarcin*).ab,ti,kf.) AND ("Systematic Reviews as Topic"/ OR "Systematic Review".pt. OR (systematicreview*).ab,ti,kf.)
  - id: LS-AFT-Cochrane-SystematicReview-2022-04-28
    label: Literatuur zoekopdracht voor Systematic Reviews on AFT in Cochrane op 2022-04-28
    end-time: 2022-04-28T00:00:00
    target-db: Cochrane
    target-url: https://www.cochranelibrary.com/
    evidence-type: Systematic Review
    query: >-
      ((((autolog*) NEAR/3 (fat*)) OR lipostruct* OR lipotransfer* OR lipomodel* OR lipofill* OR ((fat*) NEAR/3 (transplant* OR graft* OR transfer* OR inject* OR infiltrate*)) OR reverseexpan*):ab,ti,kw) AND ((mammaplast* OR mammoplast* OR mastoplast* OR mastectom* OR ((breast* OR mamma*) NEAR/3 (tumor* OR tumour* OR neoplas* OR carcino* OR cancer* OR malignan*)) OR ((breast* OR mamma*) NEAR/6 (oncol*)) OR mammacarcin*):ab,ti,kw) AND ((systematic-review*):ab,ti,kw)

publications:
  - id: Manuscript-BREAST
    type: Manuscript
    title: "Eindverslag gegevens Autologe Vettransplantatie (AFT) bij borstreconstructie na borstkanker; de techniek van de toekomst bij borstreconstructies."
    authors: [ZonMw]
    year: 2022

literature-reference-lists:
  - id: LRL-AFT
    title: Literatuur referentielijst voor AFT
    number-of-items: 1
    references:
    - Manuscript-BREAST

studies:
  - id: Study-BREAST
    title: "Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy (BREAST)"
    short-title: BREAST
    registry: Clinicaltrials.gov
    registry-id: NCT02339779
    start-date: 2015-10
    end-date: 2026-10
    study-type: Interventional
    phase: 
    sponsor: Maastricht University Medical Center
    url: https://clinicaltrials.gov/study/NCT02339779
    publication-ids:
    - Manuscript-BREAST

cohorts:
  - id: Cohort-BREAST-Intervention
    study-id: Study-BREAST
    intervention-group-id: InterventionGroup-MammaOnco-Intervention
  - id: Cohort-BREAST-Comparator # IBR
    study-id: Study-BREAST
    intervention-group-id: InterventionGroup-MammaOnco-Comparator

outcome-measurements:
  - id: OutcomeMeasurement-BreastvolumeRetention-SMD
    type: standardized mean difference
    outcome-id: Outcome-BreastvolumeRetention
    cohort-ids: [Cohort-BREAST-Intervention, Cohort-BREAST-Comparator]
    value: -9.9
    unit: ml
    ci-lower: -37.04
    ci-upper: 17.24
  - id: OutcomeMeasurement-SeriousPerioperativeComplications-RR
    type: risk ratio
    outcome-id: Outcome-SeriousPerioperativeComplications
    cohort-ids: [Cohort-BREAST-Intervention, Cohort-BREAST-Comparator]
    value: 0.18
    unit: 
    ci-lower: 0.04
    ci-upper: 0.76
  - id: OutcomeMeasurement-SeriousPerioperativeComplications-AbsoluteDifference
    type: absolute difference
    outcome-id: Outcome-SeriousPerioperativeComplications
    cohort-ids: [Cohort-BREAST-Intervention, Cohort-BREAST-Comparator]
    value: -14.5
    unit: '%'
    ci-lower: -169
    ci-upper: -42
  - id: OutcomeMeasurement-LocoregionalOncologicEvents-RR
    type: risk ratio
    outcome-id: Outcome-LocoregionalOncologicEvents
    cohort-ids: [Cohort-BREAST-Intervention, Cohort-BREAST-Comparator]
    value: 0.85
    unit: 
    ci-lower: 3.03
    ci-upper: 0.24
  - id: OutcomeMeasurement-LocoregionalOncologicEvents-AbsoluteDifference
    type: absolute difference
    outcome-id: Outcome-LocoregionalOncologicEvents
    cohort-ids: [Cohort-BREAST-Intervention, Cohort-BREAST-Comparator]
    value: -1.1
    unit: '%'
    ci-lower: -6.2
    ci-upper: 149
  - id: OutcomeMeasurement-BREASTQPatientSatisfactionWithBreast-MD
    type: mean difference
    outcome-id: Outcome-BREASTQPatientSatisfactionWithBreast
    cohort-ids: [Cohort-BREAST-Intervention, Cohort-BREAST-Comparator]
    value: 9.9
    unit: 
    ci-lower: 3.92
    ci-upper: 15.88
  - id: OutcomeMeasurement-BREASTQPhysicalWellbeing-MD
    type: mean difference
    outcome-id: Outcome-BREASTQPhysicalWellbeing
    cohort-ids: [Cohort-BREAST-Intervention, Cohort-BREAST-Comparator]
    value: 7.6
    unit: 
    ci-lower: 2.19
    ci-upper: 13.01
  - id: OutcomeMeasurement-BREASTQSexualWellbeing-MD
    type: mean difference
    outcome-id: Outcome-BREASTQSexualWellbeing
    cohort-ids: [Cohort-BREAST-Intervention, Cohort-BREAST-Comparator]
    value: 2.9
    unit: 
    ci-lower: -3.47
    ci-upper: 9.27
  - id: OutcomeMeasurement-BREASTQPsychosocialWellbeing-MD
    type: mean difference
    outcome-id: Outcome-BREASTQPsychosocialWellbeing
    cohort-ids: [Cohort-BREAST-Intervention, Cohort-BREAST-Comparator]
    value: 1.3
    unit: 
    ci-lower: 4.72
    ci-upper: 7.32

bias:
  - id: BIA-AFT
    title: Budget Impact Analyse voor AFT
    trend-assumption-id: TrendAssumption-AFT
    cost-estimation-ids: [ CostEstimation-AFT ]

scenarios:
  - id: Scenario-AFT-low
    title: Scenario met minimum aantal AFT-gebruik
    description: Scenario met minimum aantal AFT-gebruik
  - id: Scenario-AFT-high
    title: Scenario met maximum aantal AFT gebruik
    description: Scenario met maximum aantal AFT gebruik

trend-assumptions:
  - id: TrendAssumption-AFT-low
    title: Geschatte trend voor AFT laag aantal borstkanker patiënten scenario
    scenario-id: Scenario-AFT-low
    time-unit: year
    number-of-patients: [ 600 ]
    intervention-market-penetration: [ 1.0 ]
  - id: TrendAssumption-AFT-high
    title: Geschatte trend voor AFT hoog aantal borstkanker patiënten scenario
    scenario-id: Scenario-AFT-high
    time-unit: year
    number-of-patients: [ 900 ]
    intervention-market-penetration: [ 1.0 ]

cost-estimations:
  - id: CostEstimation-AFT-Substitution-low
    title: Kostenraming voor AFT laag aantal borstkanker patiënten scenario
    trend-assumption-id: TrendAssumption-AFT-low
    scenario-id: Scenario-AFT-low
    observation-groups:
    - type: Current
      intervention-ids: [ Intervention-IBR ]
      number-of-patients: [ 510 ]
      total-costs: [ 4_054_500 ]
    - type: Current
      intervention-ids: [ Intervention-ABR ]
      number-of-patients: [ 90 ]
      total-costs: [ 1_304_100 ]
    - type: Substitution
      intervention-ids: [ Intervention-AFT-BRAVA ]
      number-of-patients: [ 600 ]
      total-costs: [ 13_356_000 ]
    - type: Additional
      intervention-ids: [ Intervention-AFT-BRAVA ]
      number-of-patients: [ 600 ]
      total-costs: [ 7_997_400 ]
    - type: Total
      intervention-ids: [ Intervention-IBR, Intervention-ABR, Intervention-AFT-BRAVA ]
      number-of-patients: [ 600 ]
      total-costs: [ 13_356_000 ]
  - id: CostEstimation-AFT-Substitution-high
    title: Kostenraming voor AFT hoog aantal borstkanker patiënten scenario
    trend-assumption-id: TrendAssumption-AFT-high
    scenario-id: Scenario-AFT-high
    observation-groups:
    - type: Current
      intervention-ids: [ Intervention-IBR ]
      number-of-patients: [ 900 ]
      total-costs: [ 6_081_750 ]
    - type: Current
      intervention-ids: [ Intervention-ABR ]
      number-of-patients: [ 900 ]
      total-costs: [ 1_956_150 ]
    - type: Substitution
      intervention-ids: [ Intervention-AFT-BRAVA ]
      number-of-patients: [ 900 ]
      total-costs: [ 20_034_000 ]
    - type: Additional
      intervention-ids: [ Intervention-AFT-BRAVA ]
      number-of-patients: [ 900 ]
      total-costs: [ 11_996_100 ]
    - type: Total
      intervention-ids: [ Intervention-IBR, Intervention-ABR, Intervention-AFT-BRAVA ]
      number-of-patients: [ 900 ]
      total-costs: [ 20_034_000 ]

appropriate-use:
  id: AU-AFT
  title: Gepast gebruik afspraken voor AFT
  agreements:
  - description: "Indicatieprotocol: aansluiten bij de indicatiecriteria en exclusiecriteria van patiënten, zoals in de BREAST-studie om in aanmerking te komen voor deze behandeling en welke professionals verantwoordelijk zijn voor de selectie van patiënten;"
  - description: Uitgebreide patiënteninformatie en richtlijnen voor professionals over hoe de patiënt voor te lichten over de voor- en nadelen van deze techniek, zodat de patiënt een weloverwogen besluit kan nemen (samen beslissen).
  - description: Procesvoorwaarden voor trainingen en opleidingseisen om deze operatietechniek uit te kunnen voeren door plastisch chirurgen, en
  - description: Procesvoorwaarden voor het opzetten van het kwaliteitsregister t.b.v. verzamelen langetermijngegevens voor kosteneffectiviteit, en risicogerichte monitoring.
